{
    "nctId": "NCT04580251",
    "briefTitle": "Ideal Marker for Targeted Axillary Dissection",
    "officialTitle": "Ideal Marker for Targeted Axillary Dissection",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Depth of marker implantation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of breast cancer, confirmed with a biopsy\n* indication of neoadjuvant therapy\n* biopsy of pathologically enlarged axillary lymph node and marking of the lymph node using one of the markers before neoadjuvant chemotherapy\n* surgical treatment after neoadjuvant chemotherapy (targeted axillary dissection)\n\nExclusion Criteria:\n\n* refusal to participate in the study\n* another treatment protocol, which does not include targeted axillary dissection",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}